List of insiders holdings for BIOCRYST PHARMACEUTICALS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 14159 capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner | 2015-02-17 16:28:27 | 10,713,686 0 | 10,713,686 | Form 13G |
| BAKER FELIX Baker Bros. Investments II L.P. Baker/Tisch Investments LP 667 L.P. Baker Brothers Life Sciences LP 14159 L.P. BAKER BROS. ADVISORS LP BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Bros. Investments L.P. 10% Owner | 2015-02-17 16:28:27 | 10,713,686 0 | 10,713,686 | Form 13G |
| Baker Bros. Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner | 2015-02-17 16:28:27 | 10,713,686 0 | 10,713,686 | Form 13G |
| Baker Brothers Life Sciences Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner | 2015-02-17 16:28:27 | 10,713,686 0 | 10,713,686 | Form 13G |
| Baker Biotech Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner | 2015-02-17 16:28:27 | 10,713,686 0 | 10,713,686 | Form 13G |
| Baker / Tisch Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner | 2015-02-17 16:28:27 | 10,713,686 0 | 10,713,686 | Form 13G |
| BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner | 2024-02-14 16:21:51 | 10,204,089 0 | 10,204,089 | Form 13G |
| Stonehouse Jon P President & CEO | 2024-01-04 16:31:49 | 1,094,770 20,000 | 1,114,770 | Form 4 |
| Babu Yarlagadda S Chief Discovery Officer | 2022-11-16 16:19:59 | 298,541 0 | 298,541 | Form 4 |
| Barnes Alane P Chief Legal Officer | 2023-12-20 16:33:27 | 293,539 0 | 293,539 | Form 4 |
| Gayer Charles K Chief Commercial Officer | 2023-12-20 16:38:04 | 274,533 0 | 274,533 | Form 4 |
| Powell Lynne Senior VP - CCO | 2019-01-29 16:21:51 | 246,281 0 | 246,281 | Form 4 |
| Thackray Helen M. Chief R&D Officer | 2024-04-02 16:21:52 | 242,139 0 | 242,139 | Form 4 |
| Grant Stuart SR VP & CFO | 2011-03-18 16:49:38 | 238,740 0 | 238,740 | Form 4 |
| Doyle Anthony Chief Financial Officer | 2023-12-20 16:35:45 | 227,444 0 | 227,444 | Form 4 |
| Sniecinski Megan Chief Business Officer | 2020-12-17 16:45:24 | 225,000 0 | 225,000 | Form 4 |
| Hutson Nancy J Director | 2023-06-15 16:33:37 | 120,890 0 | 120,890 | Form 4 |
| LEE KENNETH B JR Director | 2023-06-15 16:42:19 | 107,935 0 | 107,935 | Form 4 |
| ASELAGE STEVE Director | 2023-06-15 16:39:06 | 102,411 0 | 102,411 | Form 4 |
| INGRAM ROBERT ALEXANDER Director | 2023-03-02 16:41:35 | 100,198 0 | 100,198 | Form 4 |
| LEVIN ALAN G Director | 2023-06-15 16:43:50 | 76,162 0 | 76,162 | Form 4 |
| ABERCROMBIE GEORGE B Director | 2023-06-15 16:28:04 | 68,683 0 | 68,683 | Form 4 |
| McKee Amy E Director | 2023-06-15 16:31:25 | 68,683 0 | 68,683 | Form 4 |
| Galson Steven K Director | 2023-06-15 16:40:41 | 68,683 0 | 68,683 | Form 4 |
| SANDERS MACHELLE Director | 2023-06-15 16:37:27 | 64,683 0 | 64,683 | Form 4 |
| MONTGOMERY JOHN A Director | 2003-11-05 11:47:58 | 46,785 9800 | 56,585 | Form 4 |
| MILANO VINCENT Director | 2024-03-04 17:25:11 | 51,997 0 | 51,997 | Form 4 |
| HEGGIE THERESA Director | 2024-03-04 16:32:01 | 51,860 0 | 51,860 | Form 4 |
| Erck Stanley C Director | 2018-11-30 16:02:47 | 48,333 0 | 48,333 | Form 4 |
| Sheridan William P Chief Medical Officer | 2022-03-14 16:21:25 | 37,954 0 | 37,954 | Form 4 |
| LOWREY ROBERT S Controller, PAO | 2012-03-29 19:28:15 | 35,000 0 | 35,000 | Form 4 |
| Patel Sanj K Director | 2017-05-25 11:57:29 | 30,000 0 | 30,000 | Form 4 |
| Cohen Fred E Director | 2018-06-22 09:29:36 | 30,000 0 | 30,000 | Form 4 |
| Jones Michael L Exec. Director, Finance - PAO | 2022-12-21 16:36:30 | 25,153 0 | 25,153 | Form 4 |
| McCullough David VP | 2012-03-19 13:12:21 | 24,124 0 | 24,124 | Form 4 |
| RIGGS RANDALL B Senior VP Business Development | 2007-05-18 12:04:07 | 23,868 0 | 23,868 | Form 4 |
| STAAB THOMAS R II Senior Vice President and CFO | 2020-02-25 16:28:09 | 18,000 0 | 18,000 | Form 4 |
| BENNETT J CLAUDE Chief Operating Officer | 2008-03-18 16:41:17 | 17,000 0 | 17,000 | Form 4 |
| SPENCER WILLIAM M III Director | 2007-05-17 18:20:30 | 15,000 0 | 15,000 | Form 4 |
| Jensen Peder Director | 2014-05-06 15:13:15 | 15,000 0 | 15,000 | Form 4 |
| SHERRILL JOSEPH H JR Director | 2007-05-17 18:27:00 | 15,000 0 | 15,000 | Form 4 |
| GORDON CARL L Director | 2006-05-18 15:43:29 | 15,000 0 | 15,000 | Form 4 |
| STEER RANDOLPH C Director | 2008-05-23 11:50:47 | 15,000 0 | 15,000 | Form 4 |
| SEIDENBERG BETH C Director | 2010-05-17 14:39:13 | 15,000 0 | 15,000 | Form 4 |
| FEATHERINGILL WILLIAM W Director 10% Owner | 2010-05-17 14:53:40 | 15,000 0 | 15,000 | Form 4 |
| Biggar Stephen R Director | 2011-05-16 18:15:42 | 15,000 0 | 15,000 | Form 4 |
| HOROVITZ ZOLA P Director | 2012-05-24 17:28:05 | 15,000 0 | 15,000 | Form 4 |
| HIGGINS JOHN L Director | 2012-05-25 10:19:34 | 15,000 0 | 15,000 | Form 4 |
| SANDERS CHARLES A Director | 2016-03-01 16:08:04 | 12,971 0 | 12,971 | Form 4 |
| BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC Indirect Beneficial Owner 10% Owner | 2003-12-11 11:56:48 | 9600 0 | 9600 | Form 13G |
| Mills Mike Principal Accounting Officer | 2010-03-12 16:34:17 | 4500 0 | 4500 | Form 4 |
| ALEXANDER W JAMES SR. VP, Chief Medical Officer | 2007-08-02 17:28:15 | 3659 0 | 3659 | Form 4 |
| BUGG CHARLES E Director | 2007-03-22 18:19:19 | 3333 0 | 3333 | Form 4 |
| DARWIN MICHAEL A Principal Accounting Officer | 2008-08-04 18:22:12 | 3048 0 | 3048 | Form 4 |
| Nugent Jonathan M VP Corp Communications | 2007-08-02 17:37:03 | 508 0 | 508 | Form 4 |